Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2004
02/19/2004WO2004014377A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
02/19/2004WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
02/19/2004WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
02/19/2004WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
02/19/2004WO2004014365A1 Phthalimide derivatives as matrix metalloproteinase inhibitors
02/19/2004WO2004014300A2 Tyrosine kinase inhibitors
02/19/2004WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders
02/19/2004WO2003086306A3 5ht2c receptor modulators
02/19/2004WO2003057213A3 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
02/19/2004WO2003027234A9 Small organic molecule regulators of cell proliferation
02/19/2004US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent
02/19/2004US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists
02/19/2004US20040034222 Phenyloxyalkylamino substituted triazine compound, useful for applying to the parts of the plants, to plant seed or to the area under cultivation as plant growth regulator
02/19/2004US20040034219 Benzothiophene derivative compounds process of preparation and use thereof
02/19/2004US20040034081 Estrogen receptor modulators
02/19/2004US20040034078 Such as 2-(2-butylamino-ethylsulfanylmethyl)-1H-benzimidazole-4-carboxylic acid amide for treatment of cancer, strokes, head trauma, and neurodengenerative diseases; solid phase synthesis
02/19/2004US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease
02/19/2004US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens
02/19/2004US20040034037 Heteroaryl compounds useful as inhibitors of GSK-3
02/19/2004US20040034034 Novel piperazine derivatives
02/19/2004US20040034031 3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines
02/19/2004US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality
02/19/2004US20040034019 Piperazine and piperidine derivatives
02/19/2004US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
02/19/2004US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings
02/19/2004DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine
02/19/2004DE10235690A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis
02/19/2004CA2495285A1 Phenylpyridazine derivatives as ligands for gaba receptors
02/19/2004CA2494942A1 Substituted benzimidazole compounds
02/19/2004CA2494298A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
02/19/2004CA2494048A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
02/19/2004CA2493908A1 Thiophene compounds
02/19/2004CA2493575A1 Tyrosine kinase inhibitors
02/19/2004CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation
02/18/2004EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
02/18/2004EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
02/18/2004EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
02/18/2004EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
02/18/2004EP1244655B1 Antithrombotic agents
02/18/2004EP1216238B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
02/18/2004EP1196410B1 Respiratory syncytial virus replication inhibitors
02/18/2004EP1183252B1 pharmaceutically active compounds
02/18/2004EP1178958B1 N-cyanomethyl amides as protease inhibitors
02/18/2004EP1049691B1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
02/18/2004CN1476446A Benzodiazepine derivative
02/18/2004CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity
02/18/2004CN1476436A Novel compounds for use as HIV protease inhibitors
02/18/2004CN1476430A Delta 1-pyrrolines used as pesticides
02/18/2004CN1476429A EP4 receptor selective agonists in treatment of osteoporosis
02/18/2004CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2
02/18/2004CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt
02/18/2004CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal
02/18/2004CN1138761C 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and use as dopamine autoreceptor (D2) agonists
02/18/2004CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
02/18/2004CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
02/17/2004US6693200 2-(substituted-phenyl)amino-imidazoline derivatives
02/17/2004US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6693121 As inhibitors of serine proteases of the coagulation cascade and compounds, used for anticoagulant therapy forprophylaxis of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases
02/17/2004US6693117 Compounds with analgesic effect
02/17/2004US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
02/17/2004US6692657 Alkenyl compound with 2,3-difluorophenyl group
02/17/2004CA2302965C Processes and intermediates for preparing anti-cancer compounds
02/12/2004WO2004013131A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
02/12/2004WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
02/12/2004WO2004013122A2 Octupolar molecules used as organic semi-conductors
02/12/2004WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
02/12/2004WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use
02/12/2004WO2004012736A1 Biaryl compounds having anti-infective activity
02/12/2004WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments
02/12/2004WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof
02/12/2004WO2002042289A8 Process for preparing 3-aryl-benzo[b]thiophenes
02/12/2004US20040030181 Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives
02/12/2004US20040030156 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain
02/12/2004US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
02/12/2004US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects
02/12/2004US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/12/2004US20040029920 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives
02/12/2004US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
02/12/2004US20040029902 2,4-Pyrimidinediamine compounds and their uses
02/12/2004US20040029898 Anticancer agents
02/12/2004US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders
02/12/2004US20040029883 Beta-amino acid compounds as integrin antagonists
02/12/2004US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
02/12/2004US20040029874 Anticoagulants; cardiovascular disorders
02/12/2004US20040029867 Anticoagulants; cardiovascular disorders
02/12/2004US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
02/12/2004US20040029862 Alzheimer's disease
02/12/2004US20040029861 Using compound containing pyridine ring
02/12/2004US20040028582 Using solvent, nonsolvent precipitation of drugs
02/12/2004US20040026663 Transition metal complexes
02/12/2004DE10234188A1 Oktupolare Moleküle als organische Halbleiter Octupolar molecules as organic semiconductors
02/12/2004DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments
02/12/2004DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments
02/12/2004CA2494593A1 4-trifluormethylpyrazolyl-substituted pyridines and pyrimidines
02/12/2004CA2494139A1 Biaryl compounds having anti-infective activity
02/12/2004CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
02/12/2004CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use